1

Mini-antibodies Reactivate tumor suppressor p53: New Promising Pathway for Malignant Treatment

News Discuss 
A critical discovery in cancer research is occurring with the use of nanobodies to re-engage dysfunctional p53. This vital malignant inhibitor protein is frequently inactivated in various forms of cancer, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story